Spectrum Pharmaceuticals, Inc. to Present Corporate Update at the 11th Annual Biotechnology Industry Organization (BIO) Investor Forum in San Francisco on October 9th

Published: Oct 02, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the 11th Annual BIO Investor Forum being held at the Palace Hotel in San Francisco. The Company presentation is on Tuesday, October 9, 2012, at 1:30 PM PT.

Back to news